Paper30190944
Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.
Kagen A and 2 others. Hepat Oncol, 2014. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI. Papers, record 30190944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30190944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23362092 | New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. | Radiology | 2013 | https://conductscience.org/library/papers/23362092 | PubMed |
| 2 | 20663969 | Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. | Radiology | 2010 | https://conductscience.org/library/papers/20663969 | PubMed |
| 3 | 16244260 | Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. | Radiology | 2005 | https://conductscience.org/library/papers/16244260 | PubMed |
| 4 | 22441909 | Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading. | J Ultrasound Med | 2012 | https://conductscience.org/library/papers/22441909 | PubMed |
| 5 | 20490505 | Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. | Eur Radiol | 2010 | https://conductscience.org/library/papers/20490505 | PubMed |
| 6 | 23362095 | Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. | Radiology | 2013 | https://conductscience.org/library/papers/23362095 | PubMed |
| 7 | 23218794 | Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. | Magn Reson Imaging | 2013 | https://conductscience.org/library/papers/23218794 | PubMed |
| 8 | 21990116 | Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. | J Magn Reson Imaging | 2012 | https://conductscience.org/library/papers/21990116 | PubMed |
| 9 | 20098330 | Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. | Invest Radiol | 2010 | https://conductscience.org/library/papers/20098330 | PubMed |
| 10 | 19457834 | Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. | AJR Am J Roentgenol | 2009 | https://conductscience.org/library/papers/19457834 | PubMed |
| 11 | 10381771 | Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. | J Pharmacol Exp Ther | 1999 | https://conductscience.org/library/papers/10381771 | PubMed |
| 12 | 21360083 | A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. | J Hepatobiliary Pancreat Sci | 2011 | https://conductscience.org/library/papers/21360083 | PubMed |
| 13 | 22891358 | Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. | Radiology | 2012 | https://conductscience.org/library/papers/22891358 | PubMed |
| 14 | 21701011 | Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI. | AJR Am J Roentgenol | 2011 | https://conductscience.org/library/papers/21701011 | PubMed |
| 15 | 7754011 | Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. | Radiology | 1995 | https://conductscience.org/library/papers/7754011 | PubMed |
| 16 | 20413759 | Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. | Radiology | 2010 | https://conductscience.org/library/papers/20413759 | PubMed |
| 17 | 20190787 | Membrane transporters in drug development. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20190787 | PubMed |
| 18 | 14527088 | Mechanisms of human hepatocarcinogenesis. | Curr Mol Med | 2003 | https://conductscience.org/library/papers/14527088 | PubMed |
| 19 | 22700119 | Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. | Insights Imaging | 2012 | https://conductscience.org/library/papers/22700119 | PubMed |
| 20 | 23778569 | Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. | Transplantation | 2013 | https://conductscience.org/library/papers/23778569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30190944
GET https://conductscience.org/api/papers/v1/30190944/references?page=2